Log In
BCIQ
Print this Print this
 

Betimol

  Manage Alerts
Collapse Summary General Information
Company Akorn Inc.
DescriptionTimolol solution
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat intraocular pressure (IOP) in patients with ocular hypertension; Treat intraocular pressure (IOP) in patients with open angle glaucoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/20/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today